🇺🇸 FDA
Patent

US 7314618

Antibodies to fibroblast growth factor (FGF23)

granted A61KA61K38/1825A61K48/00

Quick answer

US patent 7314618 (Antibodies to fibroblast growth factor (FGF23)) held by Ludwig-Maximilians-Universitat Munchen expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/1825, A61K48/00, A61P, A61P13/12